Improving the Treatment of Ovarian Cancer with Powerful microRNAs that Overcome the Resistance of Chemotherapy
In China, there are nearly 4.5 million cancer patients and lung cancer is the most common type
Research for Developing New Markers and Targets in Colorectal Cancer: A Novel Tumor Suppressor Gene in Colorectal Cancer
Developing reliable biomarkers for predicting the risk of metastasis/recurrence for individual colorectal cancer patients
Identifying Biomarkers of Esophageal Cancer: Developing a Screening Test for Early Detection To Improve Survival
Gastric cancer is the fourth most common cancer and the second leading cause of cancer death worldwide.
Integrating international resources to promote collaboration and accelerate cancer research
Room 2914, Hong Kong Plaza, 188 Connaught Road West, Hong Kong
Tel: (852) 2156 9684 | Fax: (852) 2156 9685
AFCR is registered in Hong Kong with the Inland Revenue Department. Our file number with the Inland Revenue Department is 91/7750. AFCR has a Certificate of Incorporation number 994957 with Company Registry.
©2020 Asian Fund for Cancer Research, All rights reserved. Website designed and maintained by USABAL Solutions